Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cavu Nutrition is a medical nutrition company dedicated to improving the lives of individuals living with rare metabolic disorders, specifically Inborn Errors of Metabolism (IEM). The company focuses on developing innovative medical foods that provide essential nutrients while managing restricted diets, such as those required for Phenylketonuria (PKU). Their flagship products are designed to be more palatable and convenient than traditional medical formulas, addressing the long-term compliance challenges faced by patients. Cavu's leadership team brings extensive experience from the clinical nutrition industry to provide patient-centric solutions. The company aims to modernize the medical food landscape by integrating better taste and nutritional science into daily disease management. Cavu is headquartered in Boulder, Colorado, and is backed by healthcare-focused venture capital.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CAVU Nutrition.